MGNI delivered exceptional financial performance with revenue growing 316% to $156.4M and net income surging 535% to $144.6M, while significantly increasing share buybacks and capital investments.
This represents a dramatic transformation in MGNI's financial profile, with revenue more than quadrupling and the company achieving substantial profitability growth. The massive increase in share buybacks (+218%) and capital expenditures (+115%) signals strong cash generation and aggressive investment in growth, though the 23% increase in current liabilities warrants monitoring for liquidity management.
MGNI demonstrated explosive growth across all key financial metrics, with revenue increasing over 300% and net income growing over 500%, while operating income nearly doubled to $97.6M. The company simultaneously reduced R&D expenses by 11% while massively increasing capital investments and share repurchases, indicating operational leverage and strong cash generation. Balance sheet strength improved with stockholders' equity growing 20% and cash increasing 15%, though the significant rise in current liabilities suggests increased operational scale and working capital needs accompanying this rapid growth phase.
Net income grew 534.7% — bottom-line growth signals improving overall business health.
Strong top-line growth of 315.5% — accelerating demand or successful expansion into new markets.
Share repurchases increased 217.6% — management returning capital, signals confidence in intrinsic value.
Capital expenditure jumped 115% — major investment cycle underway; assess returns on deployment.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Current liabilities rose 23.1% — increased short-term obligations, watch current ratio.
Equity base grew 20.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Cash grew 14.5% — improving liquidity position supports investment and shareholder returns.
R&D spending cut 11.1% — could signal cost discipline or concerning reduction in innovation investment.
Asset base grew 10.8% — expansion through organic growth, acquisitions, or capital deployment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →